FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys
Image Credit: The New York Times Health

FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys

Watchdoq July 18, 2025
Three patients with a deadly muscle-wasting disease died from liver failure after taking the therapy, Ele­vidys, or a similar treatment.

Read Full Article